Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction study of DWC20155 and DWC20156
NCT02704559Phase 1Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Dec 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of DWC20155 and DWC20156 in gastritis (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Peak Plasma Concentration and Area under the plasma concentration versus time curve. Started Dec 2015; status: completed.
02
Drugs
DWC20155DWC20156
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT02704559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704559.